SectorPharmaceutical
Established Date--
Listing Date11/02/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees1
Fiscal Year Ends31/12
Security TypeCommon stock
Office address315 Montgomery Street, 10th Floor, San Francisco, California 94104
Business
IntroductionGT Biopharma, Inc., was incorporated in California in 1965. The Company is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products with a proprietary tri-specific killer adapter fusion protein immune cell adapter technology platform. TriKE can be designed to target any number of tumor antigens in hematological malignancies or solid tumors and does not require patient-specific customization.
